Massimo Collino
- Biochemistry top 0.5%
- Eicosanoids and Hypertension Pharmacology 10
- Clinical Biochemistry top 1%
- Advanced Glycation End Products research 19
- Nephrology top 2%
-
- Diet, Metabolism, and Disease 18
- Neurology top 2%
-
- Cardiac Ischemia and Reperfusion 14
-
- Immune Response and Inflammation 13
-
- Liver Disease Diagnosis and Treatment 12
- Sepsis Diagnosis and Treatment 12
-
- Inflammasome and immune disorders 12
- Co-authors
- Christoph ThiemermannRoberto FantozziFausto ChiazzaManuela AragnoRaffaella MastrocolaElisa BenettiNimesh S. A. PatelMargherita Gallicchio
- Journals
- Frontiers in Immunology (9 papers)British Journal of Pharmacology (7 papers)Shock (7 papers)
- Partner nations
- ItalyUnited KingdomGermany
In The Last Decade
Massimo Collino
140 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 125
- Biochemistry 525
- Clinical Biochemistry 419
- Nephrology 326
- Endocrinology, Diabetes and Metabolism 715
- Neurology 313
Countries citing papers authored by Massimo Collino
This map shows the geographic impact of Massimo Collino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Collino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Collino more than expected).
Fields of papers citing papers by Massimo Collino
This network shows the impact of papers produced by Massimo Collino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Collino. The network helps show where Massimo Collino may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Massimo Collino, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 83 | |
| 4 | 2023 | 11 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 24 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 56 | |
| 12 | 2020 | 29 | |
| 13 | 2019 | 25 | |
| 14 | Pharmacological rationale for tapentadol therapy: a review of new evidence | 2019 | 1 |
| 15 | Tapentadol: an overview of the safety profile | 2019 | 0 |
| 16 | Role of the beta-d-endoglucuronidase heparanase in septic cardiomyopathy | 2017 | 2 |
| 17 | 2017 | 55 | |
| 18 | 2016 | 131 | |
| 19 | 2015 | 58 | |
| 20 | 2010 | 65 |
About Massimo Collino
Massimo Collino is a scholar working on Clinical Biochemistry, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 141 papers that have together received 5.1k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (19 papers), Diet, Metabolism, and Disease (18 papers), Cardiac Ischemia and Reperfusion (14 papers), Immune Response and Inflammation (13 papers), Liver Disease Diagnosis and Treatment (12 papers), Inflammasome and immune disorders (12 papers), Sepsis Diagnosis and Treatment (12 papers) and Eicosanoids and Hypertension Pharmacology (10 papers). The work is most often cited by research in Biochemistry (525 citations), Clinical Biochemistry (419 citations) and Nephrology (326 citations). Massimo Collino has collaborated with scholars based in Italy, United Kingdom and Germany. Frequent co-authors include Christoph Thiemermann, Roberto Fantozzi, Fausto Chiazza, Manuela Aragno, Raffaella Mastrocola, Elisa Benetti, Nimesh S. A. Patel, Margherita Gallicchio, Arianna Carolina Rosa and Chiara Dianzani. Their work appears in journals such as Frontiers in Immunology, British Journal of Pharmacology, Shock, Oxidative Medicine and Cellular Longevity and Free Radical Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.